Virtually all studies have shown very high safety profiles for nutritional supplements in the treatment of dyslipidemia. In the section below, all the efficacy studies, adverse effects and safety ...

Background/Objectives: Dyslipidemia during adolescence has been associated with in-creased risk of cardiovascular disease throughout life; however, its prevalence and anthropometric predictors remain ...

One potentially modifiable risk factor for CVD in patients with CKD is dyslipidemia. In the current manuscript we review observational and trial data assessing dyslipidemia and its treatment in ...

The future of treating metabolic dysfunction–associated steatohepatitis (MASH) looks brighter than ever, says Naim Alkhouri, MD, as data emerges on newly developed interventions.

The PROLONG-ANG3 trial showed that solbinsiran at the 400 mg dose reduced apolipoprotein B (apoB) concentration in patients with statin-treated mixed dyslipidemia and was generally well tolerated.

With no endometriosis as our reference, we evaluated the associations between endometriosis diagnosis, stage (I/II vs III/IV), and typology (SE, OE, DE, OE+DE) and dyslipidemia using standard clinical ...

Biomimetic synthesis is a branch of natural product synthesis that aims to synthesize a target molecule through a series of reactions, and passing through intermediate structures, that are closely ...

Microsoft Program Synthesis using Examples SDK is a framework of technologies for the automatic generation of programs from input-output examples. This repo includes samples and sample data for the ...

TripoSG is an advanced high-fidelity, high-quality and high-generalizability image-to-3D generation foundation model. It leverages large-scale rectified flow transformers, hybrid supervised training, ...